Collectively, these studies elucidate various aspects of dopaminergic and monoaminergic dysfunctions in ADHD, emphasizing the interplay between dopamine synthesis, DAT availability, receptor regulation, and pharmacological modulation. Here, SLC6A3 is linked to attention deficit-hyperactivity disorder.